Company intelligence / Profile preview

Leeuwenhoek Laboratories Co., Ltd.

Ownership: Private
Development stage: Other

Overview

The company has developed personalized health assessment technology using miniature mass spectrometry detection and has established the world's largest A. muciniphila biobank with 112 strains isolated from healthy individuals[3][4]

Therapeutic areas: Metabolic Disorders
Modalities: Probiotics, particularly next-generation probiotics
Industry: Biotech

Drug pipeline

1 asset

Pasteurized Akkermansia muciniphila LWHK0003

Partnerships

Collaboration with MERRYDAY (nutrition supplement brand)CommonWealth Magazine[3]

Beyond the preview

Go deeper on Leeuwenhoek Laboratories Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leeuwenhoek Laboratories Co., Ltd..